Sacha T. Early molecular response as a criterion of optimal response to chronic myeloid leukemia treatment with tyrosine kinase inhibitors. OncoReview [Internet]. 2013Jun.28 [cited 2024Nov.23];3(2(10):80-4. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/333